<p><h1>NGS-based RNA-seq Market Size Reflecting a Forecast Till 2031: Market By Type, By Application and By Geography</h1></p><p><strong>NGS-based RNA-seq Market Analysis and Latest Trends</strong></p>
<p><p>NGS-based RNA-seq (Next-Generation Sequencing-based RNA sequencing) is a high-throughput sequencing technique used to analyze and quantify gene expression and transcriptome profiling. It enables researchers to study RNA molecules in a genome-wide manner and provides valuable insights into gene regulation, biomarker discovery, and disease characterization.</p><p>The NGS-based RNA-seq market has experienced significant growth in recent years and is projected to continue its upward trajectory in the coming years. The market growth is driven by several factors, including technological advancements in NGS platforms, increasing applications of RNA-seq in various research areas, and growing adoption of personalized medicine.</p><p>One of the key trends in the NGS-based RNA-seq market is the increasing use of single-cell RNA-seq (scRNA-seq) technology. This technique allows researchers to study gene expression at the single-cell level, providing a deeper understanding of cellular heterogeneity and enabling the identification of rare cell types. scRNA-seq is widely used in fields such as cancer research, developmental biology, and neurobiology.</p><p>Another trend is the integration of RNA-seq with other omics technologies, such as genomics and proteomics, to obtain a comprehensive understanding of biological processes. Integrative multi-omics approaches are being adopted to unravel complex biological mechanisms, identify therapeutic targets, and develop precision medicine strategies.</p><p>Furthermore, the NGS-based RNA-seq market is witnessing increased demand for bioinformatics tools and analysis workflows to handle the large volume of data generated by RNA-seq experiments. This has resulted in the development of user-friendly software solutions for data analysis, differential gene expression, and pathway analysis.</p><p>In conclusion, the NGS-based RNA-seq market is poised for substantial growth with a forecasted CAGR of 9.8% during the forecast period. The increasing applications of RNA-seq, advancements in sequencing technologies, the emergence of scRNA-seq, and the integration of multi-omics approaches are key market trends to watch out for. Additionally, the demand for bioinformatics tools and analysis workflows is expected to rise along with the expanding market.</p></p>
<p><strong>Get a Sample PDF of the Report:&nbsp;</strong> <a href="https://www.reliableresearchreports.com/enquiry/request-sample/1231558">https://www.reliableresearchreports.com/enquiry/request-sample/1231558</a></p>
<p>&nbsp;</p>
<p><strong>NGS-based RNA-seq Major Market Players</strong></p>
<p><p>The NGS-based RNA-seq Market is highly competitive and is led by several major players in the industry, including Illumina, Thermo Fisher Scientific, Pacific Biosciences Of California, Qaigen, F. Hoffmann-La Roche, Agilent Technologies, Oxford Nanopore Technologies, Perkinelmer, Eurofins Scientific, Gatc Biotech, and Macrogen.</p><p>Illumina is one of the key players in the market and holds a significant market share. The company has a strong presence globally and offers a wide range of NGS-based RNA-seq products and services. Illumina's market growth has been driven by its advanced technology, high-quality sequencing solutions, and a strong customer base. The company has focused on strategic partnerships and collaborations to enhance its product portfolio and expand its market reach. Illumina's future growth is expected to be driven by increasing demand for personalized medicine, genomics research, and the development of precision medicine.</p><p>Thermo Fisher Scientific is another leading player in the NGS-based RNA-seq market. The company offers a comprehensive suite of RNA sequencing solutions, including library preparation kits, sequencing platforms, and bioinformatics tools. Thermo Fisher Scientific has experienced significant market growth due to its robust technology platforms and a wide range of product offerings. The company has also focused on expanding its market presence through acquisitions and strategic collaborations. Thermo Fisher Scientific's future growth is expected to be driven by increasing demand for genomic analysis in clinical diagnostics and research applications.</p><p>Agilent Technologies is a prominent player in the NGS-based RNA-seq market, offering a wide range of products, including library preparation kits, high-throughput sequencing systems, and analytical software. The company's market growth has been driven by its strong focus on innovation, high-quality products, and excellent customer support. Agilent Technologies has a strong global presence and is focused on expanding its market reach through collaborations and strategic partnerships. The future growth of Agilent Technologies is expected to be driven by increasing demand for NGS-based RNA-seq in clinical diagnostics and forensics applications.</p><p>The sales revenue of these companies varies, with Illumina being the market leader and recording annual sales revenue of approximately $3.54 billion in 2020. Thermo Fisher Scientific reported sales revenue of approximately $32.22 billion, while Agilent Technologies reported sales revenue of approximately $5.34 billion in the same year. The market size of the NGS-based RNA-seq market is expected to witness significant growth in the coming years due to the increasing adoption of NGS-based technologies in various applications, such as clinical diagnostics, drug discovery, and agricultural research.</p></p>
<p>&nbsp;</p>
<p><strong>What Are The Key Opportunities For NGS-based RNA-seq Manufacturers?</strong></p>
<p><p>The NGS-based RNA-seq market has experienced significant growth in recent years and is expected to continue its upward trend in the foreseeable future. This is primarily driven by the increasing demand for personalized medicine and the need for precise gene expression analysis. The data generated by NGS-based RNA-seq offers comprehensive insights into gene regulation and functionality, enabling researchers to study disease mechanisms and identify therapeutic targets. Moreover, the market is witnessing advancements in sequencing technologies and bioinformatics tools, which enhance data analysis and interpretation. As a result, the NGS-based RNA-seq market's future outlook appears to be promising, with continued growth and potential for further research and development.</p></p>
<p><strong>Inquire or Share Your Questions If Any Before Purchasing This Report:</strong> <a href="https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1231558">https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/1231558</a></p>
<p>&nbsp;</p>
<p><strong>Market Segmentation</strong></p>
<p><strong>The NGS-based RNA-seq Market Analysis by types is segmented into:</strong></p>
<p><ul><li>High-Throughput Sequencing</li><li>Third-Generation Sequencing Technology</li></ul></p>
<p><p>The NGS-based RNA-seq market refers to the market for next-generation sequencing technologies used to study RNA molecules. High-throughput sequencing is a type of NGS technology that allows for the simultaneous sequencing of multiple RNA samples, enabling researchers to analyze large-scale gene expression patterns. On the other hand, third-generation sequencing technology is a more advanced type of NGS that provides longer read lengths and can directly sequence RNA molecules without the need for prior conversion to DNA. Both technologies have revolutionized RNA research and are widely used in various scientific fields.</p></p>
<p><strong>Purchase this Report:&nbsp;</strong><a href="https://www.reliableresearchreports.com/purchase/1231558">https://www.reliableresearchreports.com/purchase/1231558</a></p>
<p>&nbsp;</p>
<p><strong>The NGS-based RNA-seq Market Industry Research by Application is segmented into:</strong></p>
<p><ul><li>Hospitals and Clinics</li><li>Biopharma Companies</li><li>Government Agencies</li><li>Academic and Research Organizations</li><li>Other</li></ul></p>
<p><p>NGS-based RNA-seq is widely used in various industries and sectors. Hospitals and clinics utilize this technology for diagnostic purposes, disease classification, and personalized medicine. Biopharma companies employ NGS-based RNA-seq to identify potential drug targets, assess drug toxicity and efficacy, and develop companion diagnostics. Government agencies utilize RNA-seq for research purposes, understanding disease outbreaks, and developing public health strategies. Academic and research organizations employ this technology for studying gene expression patterns, identifying biomarkers, and understanding disease mechanisms. Other markets, including agriculture and environmental sectors, use NGS-based RNA-seq for gene expression profiling and studying diverse biological processes.</p></p>
<p>&nbsp;</p>
<p><strong>In terms of Region, the NGS-based RNA-seq Market Players available by Region are:</strong></p>
<p>
    <p> <strong> North America: </strong>
        <ul>
            <li>United States</li>
            <li>Canada</li>
        </ul>
        </p> 
    <p> <strong> Europe: </strong>
        <ul>
            <li>Germany</li>
            <li>France</li>
            <li>U.K.</li>
            <li>Italy</li>
            <li>Russia</li>
        </ul>
        </p> 
    <p> <strong> Asia-Pacific: </strong>
        <ul>
            <li>China</li>
            <li>Japan</li>
            <li>South Korea</li>
            <li>India</li>
            <li>Australia</li>
            <li>China Taiwan</li>
            <li>Indonesia</li>
            <li>Thailand</li>
            <li>Malaysia</li>
        </ul>
        </p> 
    <p> <strong> Latin America: </strong>
        <ul>
            <li>Mexico</li>
            <li>Brazil</li>
            <li>Argentina Korea</li>
            <li>Colombia</li>
        </ul>
        </p> 
    <p> <strong> Middle East & Africa: </strong>
        <ul>
            <li>Turkey</li>
            <li>Saudi</li>
            <li>Arabia</li>
            <li>UAE</li>
            <li>Korea</li>
        </ul>
    </p>
    </p>
<p><p>The NGS-based RNA-seq market is anticipated to showcase substantial growth across various regions, including North America (NA), Asia Pacific (APAC), Europe, the USA, and China. Among these, North America and Europe are expected to dominate the market due to the presence of well-established healthcare infrastructure, constant technological advancements, and increasing research and development activities. North America is projected to hold the largest market share, accounting for approximately 40%, followed by Europe with a share of around 30%. The APAC region is also expected to witness significant growth, contributing approximately 20% to the market's value, while the USA and China are estimated to hold around 5% each.</p></p>
<p><strong>Purchase this Report: </strong><a href="https://www.reliableresearchreports.com/purchase/1231558">https://www.reliableresearchreports.com/purchase/1231558</a></p>
<p>&nbsp;<strong>Get a Sample PDF of the Report:&nbsp;&nbsp;</strong><a href="https://www.reliableresearchreports.com/enquiry/request-sample/1231558">https://www.reliableresearchreports.com/enquiry/request-sample/1231558</a></p>
<p><strong></strong></p>
<p><p><a href="https://medium.com/@sarahchavez1995/lms-for-education-market-size-and-market-trends-complete-industry-overview-2023-to-2030-95e66ffe3635">LMS for Education Market</a></p><p><a href="https://medium.com/@angelageorge32/gas-management-market-competitive-analysis-market-trends-and-forecast-to-2030-91f179b752ac">Gas Management Market</a></p></p>